SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-297661
Filing Date
2018-10-11
Accepted
2018-10-11 16:23:35
Documents
9
Effectiveness Date
2018-10-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d622490ddefa14a.htm DEFA14A 35112
2 GRAPHIC g622490001.jpg GRAPHIC 42470
3 GRAPHIC g622490002.jpg GRAPHIC 24228
4 GRAPHIC g622490003.jpg GRAPHIC 7435
5 GRAPHIC g622490004.jpg GRAPHIC 19612
6 GRAPHIC g622490005.jpg GRAPHIC 8044
7 GRAPHIC g622490006.jpg GRAPHIC 2605
8 GRAPHIC g622490007.jpg GRAPHIC 3944
9 GRAPHIC g622490008.jpg GRAPHIC 4581
  Complete submission text file 0001193125-18-297661.txt   192772
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 181118550
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1